Figure 1.
Kaplan-Meier estimates of median OS and EFS. (A) Median OS for all patients was found to be 12.2 months (range, 0.2-36.2 months). (B) Median OS landmarked from the date of transplantation was NR (range, 2.3-34.1 months). (C) Median EFS for all patients was NR (range, 0.5-14.2 months). (D) Median OS of patients with TP53wt vs TP53mut (13.6 vs 8.6 months). (E) Median OS of patients naïve to hypomethylating therapy (HMA) vs patients exposed to HMA (10.2 vs 12.2 months).

Kaplan-Meier estimates of median OS and EFS. (A) Median OS for all patients was found to be 12.2 months (range, 0.2-36.2 months). (B) Median OS landmarked from the date of transplantation was NR (range, 2.3-34.1 months). (C) Median EFS for all patients was NR (range, 0.5-14.2 months). (D) Median OS of patients with TP53wt vs TP53mut (13.6 vs 8.6 months). (E) Median OS of patients naïve to hypomethylating therapy (HMA) vs patients exposed to HMA (10.2 vs 12.2 months).

Close Modal

or Create an Account

Close Modal
Close Modal